Growth Metrics

Nexalin Technology (NXL) EBT Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.50%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.02%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 54.33%
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -5.51%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.51%
Dec 31, 2025 16.13%
Sep 30, 2025 7.03%
Jun 30, 2025 -23.21%
Mar 31, 2025 -89.82%
Dec 31, 2024 -262.95%
Sep 30, 2024 -6.58%
Jun 30, 2024 -56.02%
Mar 31, 2024 -39.89%
Dec 31, 2023 -6.49%
Sep 30, 2023 -656.54%
Jun 30, 2023 -84.77%
Mar 31, 2023 -90.32%
Dec 31, 2022 -23.02%
Sep 30, 2022 83.34%